K145 是一种选择性的,具有底物竞争性和口服活性的SphK2抑制剂,IC50为 4.3 μM,Ki为 6.4 μM。K145 对 SphK1 和其他蛋白激酶没有活性。K145 可诱导细胞凋亡,并具有强大的抗肿瘤活性。
生物活性 | K145 is a selective, substrate-competitive and orally activeSphK2inhibitor with anIC50of 4.3 μM and aKiof 6.4 μM. K145 is inactive againstSphK1and other protein kinases. K145 induces cellapoptosisand has potently antitumor activity[1]. |
IC50& Target | IC50: 4.3 μM (SphK2)[1] Ki: 6.4 μM (SphK2)[1] |
体外研究 (In Vitro) | K145 (0-10 μM; 24-72 hours; U937 cells) treatment significantly inhibits the growth of U937 cells in a concentration-dependent manner[1]. K145 (10 μM; 24 hours; U937 cells) treatment significantly induces apoptosis in U937 cells[1]. K145 (4-8 μM; 3 hours; U937 cells) treatment decreases the phosphorylation of ERK and Akt[1]. Treatment with K145 (10 μM) causes a decrease of total cellular S1P without significant effects on ceramide levels[1].
Cell Viability Assay[1] Cell Line: | U937 cells | Concentration: | 0 μM, 4 μM, 6 μM, 8 μM, 10 μM | Incubation Time: | 24 hours, 48 hours, 72 hours | Result: | Significantly inhibited the growth of U937 cells in a concentration-dependent manner. |
Apoptosis Analysis[1] Cell Line: | U937 cells | Concentration: | 10 μM | Incubation Time: | 24 hours | Result: | Significantly induced apoptosis in U937 cells. |
Western Blot Analysis[1] Cell Line: | U937 cells | Concentration: | 4 μM, 8 μM | Incubation Time: | 3 hours | Result: | Phosphorylated ERK and Akt were decreased. |
|
体内研究 (In Vivo) | K145 (50 mg/kg; oral gavage; daily; for 15 days; BALB/c-nu mice) treatment significantly inhibits the growth of U937 tumors in nude mice[1].
Animal Model: | BALB/c-nu mice injected with U937 cells[1] | Dosage: | 50 mg/kg | Administration: | Oral gavage; daily; for 15 days | Result: | Oral gavage; daily; for 15 daysInhibited the growth of U937 tumors at 50 mg/kg dose and no apparent toxicity was observed. |
|
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |